Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing

The Lead

Potential Billion-Dollar Verdict Rests on Disputed Deadline

March 27, 2015 | by ADAM BEAM, Associated Press | News | Comments

What does it cost to miss a deadline? For the company that makes the prescription painkiller Oxycontin, the answer could be more than $1 billion.

TOPICS:
View Sample

FREE Daily Email Newsletter

Sagent Pharmaceuticals Announces Leadership Changes

March 27, 2015 8:10 am | News | Comments

The Board of Directors of Sagent Pharmaceuticals has announced that Jeffrey Yordon, Chairman and Chief Executive Officer, has informed the Board of his decision to retire from the company.

TOPICS:

Developing Flexibility and Efficiency in Biomanufacturing Facilities

March 27, 2015 8:05 am | by Jeff Odum, CPIP, Biopharmaceutical Market Leader, IPS | News | Comments

Current developments in the biopharmaceutical industry have added significantly to the challenges of designing, building, and operating biopharmaceutical manufacturing facilities.

TOPICS:

Recipharm and Adroit Science Form Collaboration to Expand Service Offering

March 26, 2015 3:53 pm | News | Comments

Recipharm AB and Adroit Science AB have announced the formation of a new strategic collaboration. Adroit Science AB will support Recipharm’s pharmaceutical development with high quality solid state characterization services

TOPICS:
Advertisement

Don’t Forget the WIP!

March 26, 2015 3:47 pm | by Andrew Christofides, P.E., Lead Engineer, Process Architecture and Technology - IPS | Blogs | Comments

The impact of work-in-process (WIP) on oral solid dosage (OSD) plant design

TOPICS:

Report: Sepsis Treatment Market to Dramatically Expand Following 2016 Drug Debut

March 26, 2015 3:33 pm | by Andy Szal, Digital Reporter | News | Comments

A new report expects the market value for sepsis treatments to increase more than thirteen-fold between 2016 and 2021 following the launch of a new sepsis-specific drug.

TOPICS:

FDA to Scrutinize Unproven Alternative Remedies

March 26, 2015 3:23 pm | by MATTHEW PERRONE, AP Health Writer | News | Comments

Federal officials plan to review the safety and evidence behind alternative remedies like Zicam and Cold-Eeze, products that are protected by federal law, but not accepted by mainstream medicine.

TOPICS:

Orexigen's Mysimba Approved in Europe for the Treatment of Obesity

March 26, 2015 3:17 pm | News | Comments

Orexigen Therapeutics has announced that the European Commission has granted marketing authorization for Mysimba (naltrexone HCl / bupropion HCl prolonged release) as an adjunct to a reduced-calorie diet and increased physical activity, for the management of weight in adult patients.

TOPICS:

Shire and Cincinnati Children's Establish Rare Disease Research Collaboration

March 26, 2015 8:17 am | News | Comments

The goal of the collaboration is to discover and develop novel therapies to treat rare diseases with high unmet medical need combining Shire's development and commercialization capabilities with Cincinnati Children's research expertise.

TOPICS:
Advertisement

AstraZeneca Joins Genomics England Consortium

March 26, 2015 8:03 am | News | Comments

AstraZeneca today announced that it has joined a public-private consortium with Genomics England to accelerate the development of new diagnostics and treatments arising from the 100,000 Genomes Project.

TOPICS:

Capsugel Investing More Than $25M in Increased Production Capacity and Quality Enhancements

March 26, 2015 7:59 am | News | Comments

Capsugel has announced that the company is investing more than $25 million to increase production capacity and deliver further quality enhancements for its vegetarian capsules.

TOPICS:

UK Prime Minister Apologizes for Tainted Blood Scandal

March 25, 2015 3:20 pm | News | Comments

British Prime Minister David Cameron on Wednesday apologized to thousands of patients who were infected from contaminated blood during the 1970s and 1980s.

TOPICS:

Designing for Potent Compound Exposure Levels – Not as Easy as 1-2-3

March 25, 2015 3:15 pm | by Paul Valerio, Director, Technology - IPS | Blogs | Comments

Defining categories for potency of pharmaceutical compounds has been invaluable to our industry.  It allows R&D to evaluate and define the potency of new compounds so they may be handled safely. 

TOPICS:

Manual Cleaning in an OSD Facility – Will It Ever Go Away??

March 25, 2015 3:08 pm | by Editor | Blogs | Comments

Manually executed cleaning techniques and procedures have been utilized to wash small change parts and equipment since the inception of oral solid dosage manufacturing.

TOPICS:

Texas Prison Agency Replenishes Execution Drug Supply

March 25, 2015 2:27 pm | by MICHAEL GRACZYK, Associated Press | News | Comments

Texas prison officials have acquired a small supply of pentobarbital to replenish their dwindling inventory of the execution drug so lethal injections set for next month can be carried out.

TOPICS:

Science, Patients Driving Rare Disease Drug Research Surge

March 25, 2015 2:24 pm | by LINDA A. JOHNSON, AP Business Writer | News | Comments

The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once drew little interest from major drugmakers but now point the way toward a new era of innovative therapies and big profits.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading